Biotech

PRISM ALS Sets Out to Improve ALS/MND Drug Discovery

A new international collaboration is building more representative stem cell models of ALS, an effort that could improve drug discovery and reduce clinical trial failure rates.

Basecamp Research Launches the Trillion Gene Atlas

Aiming to Redefine the Data Foundations of AI-Driven Drug Discovery, the landmark initiative partners with Anthropic, Ultima Genomics, PacBio and NVIDIA to generate and model biological data at an unprecedented scale.

Free Lab Software Aims to Ease the Data Management Burden for Academic Researchers

UK startup Lab Thread has made its unified lab platform free for small academic and non-profit labs, a move that could lower the barrier to rigorous data management for early-stage biological research.

Antiverse Targets Drug Discovery's "Undruggable" Frontier with AI-Driven Antibodies

AI-designed antibodies could unlock more than half of GPCR targets that have long resisted traditional drug discovery.

Mursla Bio joins ABHI US Accelerator for EvoLiver rollout

Programme will support US market access and early clinical adoption of the company’s liver cancer surveillance blood test.

NICE approves first licensed vitiligo treatment for NHS use in England

First licensed vitiligo therapy underscores opportunities for innovation, pipeline prioritisation, and market access in autoimmune skin disorders.